HIV Infection: A Chronic Disease
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: closed (30 April 2021) | Viewed by 5470
Special Issue Editor
Special Issue Information
Dear colleagues,
HIV infection today still causes thousands of deaths worldwide. Due to critical socio-cultural conditions in many countries we still encounter vertically acquired HIV, giving a lifelong burden to our children HIV infected.
ART therapies guarantee a normal life to these children, with some side effects that we need to study deeply. Moreover, vertically acquired HIV produces cultural and social stigma and worries that we are still not able to manage efficiently. I make every day my clinical efforts in treat at 360° my patients, from birth to adults life; for this is very important the collaboration of the pediatrician with the infectious disease specialists, as well as with gynecologists to address the problem of maternity in young HIV- infected women. In this panorama of HIV infection there are still many problems and some topic are yet to be defined:
- HIV and coinfection: clinical and therapeutics interference
- HIV and COVID-19: have we learnt something new about immunodeficiency? Did COVID-19 infection aggravate the acquired immunodeficiency status?
- HIV and parenthood: which possibility can we guarantee to our patients?
- HIV and ART therapies: what's new on drug resistance
- HIV and drug adverse effect
- HIV and social behavior
Prof. Vania Giacomet
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HIV
- COVID-19
- ART therapies
- vertically acquired HIV
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.